M&As this week: Crown Laboratories, MidOcean Partners, Colgate-Palmolive
Crown Laboratories has acquired Vita Liberata for an undisclosed sum.
Focus:
Crown Laboratories has acquired Vita Liberata for an undisclosed sum.
Peerfit has announced that it has raised $10.31m in Series B funding.
North Haven Private Equity Asia has entered an agreement with Giorgos Korres to purchase a 70% stake in Nissos Holdings for €48.3m ($57.30m).
Titan Biotech intends to raise funds by issuing bonds, debentures and securities on preferential basis.
Bod Australia has raised A$3.2m ($2.44m) through a private placement of 10 million shares.
Isodiol International has agreed to acquire BioSynthesis Pharma Group for $12.5m.
US-based personal care company Helen of Troy has sold its nutritional supplements and skincare business Healthy Directions to Direct Digital.
Goldman Sachs & Co is purchasing 10,000,000 of Univar's common stock shares from Clayton, Dubilier & Rice (CD&R).
US-based beauty care and household products manufacturer Delta Brands has acquired Personal Care Products' (PCP) assets.
Emami Limited has acquired a 30% stake in men’s grooming products retailer Helios Lifestyle.